Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Research models requiring systemic inflammation modulation (dermal, joint, or distributed immune tissue) require injectable KPV administered subcutaneously, which achieves 8095% bioavailability and therapeutic plasma levels oral formulations cannot provide
GHK-Cu has been shown in cell culture to increase dermal papilla cell proliferation and protect these cells from programmed cell death (apoptosis), shifting the Bcl-2/Bax survival balance in favor of cell protection
Edetic Acid, Monopotassium Salt 34
Diabetes 63 , 41974205 (2014)
US$ 22.01
US$ 21.26
US$ 28.24
US$ 27.50
US$ 29.92
